This site is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa logo

Workshop: Redefining HPV & STI Diagnostics: Innovations for a Healthier Future

Workshop: Redefining HPV & STI Diagnostics


By Seegene Inc. (In collaboration with Inqaba Biotec West Africa)

📅Tuesday 3rd June | 13:00 - 15:00
📍Room 1D

Session overview

The session is a comprehensive summary on the state of HPV and STI epidemiology globally and in Africa. The importance of molecular testing will be investigated and the different methods compared and evaluated.

The screening algorithms globally will be discussed with regards to their relevance in the African context. Also, the growing concern of drug resistance will be discussed and how this can be tested and managed.

Lastly, we will look at the applicability of Seegene Assays to address these concerns discussed.

Learning objectives

  • Understanding the problem of STIs and HPV
  • Becoming acquainted with the testing and screening algorithms
  • Understanding the way forward in molecular diagnostics

Company bio

Inqaba biotec

Inqaba Biotec West Africa (IBWA) is a subsidiary of Inqaba Biotechnical Industries (Pty) Ltd, South Africa. The company was incorporated in 2014 and located opposite IITA in Ibadan, Nigeria. Currently, IBWA also operates in Ghana, Senegal, Cameroon, Benin Republic, and Mali, having established itself as a leader in delivering high-quality laboratory products, equipment, and services. Our core services include, oligonucleotide synthesis, Sanger DNA sequencing, Next Generation Sequencing, bioinformatics, molecular diagnostics, fragment analysis, as well as workshops and instrument maintenance.

Presenters

Technically orientated scientist with interpersonal aptitude and extensive experience in Molecular Diagnostics. Sales success has always been based on sincere product expertise and open client communication. Using the philosophy of integrity in sales increased the Molecular Diagnostic portfolio to be the single largest revenue generating entity within Inqaba Biotec. Created the local subsidiary of Seegene to create a more direct, technical based link with the Sub-Saharan territories.



Mr Victor holds a Bachelor’s degree in Medical Laboratory Science with Medical Microbiology specialty, Master in Disaster Risk Management and Development Study and currently enrolled in M.Phil./Ph.D. Public Health program in Nasarawa State University, Keffi.



Dr. Coker holds a PhD in Epidemiology from the University of Maryland School of Medicine (2015), a Master of Public Health from Johns Hopkins Bloomberg School of Public Health (2007), and a Bachelor of Dental Surgery from the University of Ibadan, Nigeria (2004). Her research focuses on characterizing the effect of early-life infections (including HIV/AIDS), behavioural and environmental factors on microbial composition in the context of oral/dental disease.